# Menghai Pu-erh (Camellia sinensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/menghai-pu-erh
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Tea Cultivars
**Also Known As:** Camellia sinensis var. assamica, Menghai Dark Tea, Yunnan Pu-erh, Chinese Fermented Tea, Sheng Pu-erh, Shou Pu-erh, Wo Dui Tea, Post-fermented Tea, Qimao Tea

## Overview

Menghai Pu-erh is a microbially fermented tea (Camellia sinensis) from Yunnan, China, distinguished by its high content of theabrownins and lovastatin-like compounds produced during pile fermentation. These bioactives inhibit HMG-CoA reductase and modulate gut microbiota composition, driving its investigated metabolic and lipid-lowering effects.

## Health Benefits

• [Antioxidant](/ingredients/condition/antioxidant) properties from modified polyphenols and theabrownins (preclinical evidence only)
• Potential cholesterol-lowering effects through inhibition of cholesterol biosynthesis (laboratory studies, no human trials)
• Possible blood sugar regulation for diabetes management (in vitro studies only, lacks human validation)
• [Antimicrobial](/ingredients/condition/immune-support) and antimutagenic activity (preliminary cell culture evidence)
• Traditional digestive aid and detoxifying properties (historical use, no clinical validation)

## Mechanism of Action

Theabrownins in Menghai Pu-erh competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis, mimicking the action of statin drugs. Gallic acid and EGCG derivatives modulate AMPK signaling pathways, enhancing [insulin sensitivity](/ingredients/condition/weight-management) and promoting GLUT4 translocation in peripheral tissues. Additionally, fermentation-derived short-chain fatty acid precursors interact with GPR41 and GPR43 receptors in the gut, shifting the Firmicutes-to-Bacteroidetes ratio and reducing lipopolysaccharide-driven systemic [inflammation](/ingredients/condition/inflammation).

## Clinical Summary

Most evidence for Menghai Pu-erh derives from in vitro cell studies and rodent models; human clinical trials are sparse and methodologically limited. A small Chinese randomized controlled trial (n=86) found that 3g/day of ripe Pu-erh tea consumed for 12 weeks reduced [LDL cholesterol](/ingredients/condition/heart-health) by approximately 8% and triglycerides by 12% compared to placebo, though blinding was inadequate. Animal studies using hyperlipidemic rat models report 20-30% reductions in serum total cholesterol at doses of 800mg/kg body weight, but these results cannot be directly extrapolated to humans. Overall, the evidence base remains preclinical-dominant, and large-scale, well-controlled human trials are needed before therapeutic claims can be substantiated.

## Nutritional Profile

Menghai Pu-erh (aged/fermented Camellia sinensis) has a distinct nutritional profile shaped by microbial fermentation during the 'wet piling' (wo dui) process. Per standard 3g dry leaf serving brewed in 200ml water: Calories ~2-4 kcal. Protein: ~0.2-0.4g per serving (leaves contain ~20-25% protein by dry weight, minimal extraction into liquor). Carbohydrates: trace (~0.5-1g soluble sugars per serving). Fat: negligible (<0.1g). Key bioactive compounds: Theabrownins (high-molecular-weight polymeric pigments unique to pu-erh) at approximately 10-40mg per gram of dry leaf, representing the dominant polyphenol fraction after fermentation — significantly higher than green or black tea. Catechins (EGCG, EGC, ECG, EC) are substantially reduced versus green tea due to microbial oxidation, typically 5-15mg/g dry leaf (vs. 80-120mg/g in green tea). Gallic acid: ~2-8mg/g dry leaf. Theaflavins: ~2-5mg/g. Caffeine: ~20-40mg per 3g serving (moderately lower than black tea). Theobromine: ~1-3mg per serving. Theanine (L-theanine): ~5-15mg per serving (reduced from green tea levels due to fermentation). Statins: lovastatin-like compounds detected at trace levels (~0.1-1mg/g in some analyses, attributed to Aspergillus niger microbial activity during fermentation — bioavailability in brewed form not established). Minerals per serving: Fluoride ~0.1-0.3mg, Manganese ~0.3-0.6mg, Potassium ~20-40mg, Magnesium ~2-5mg, Zinc ~0.05-0.1mg. Vitamins: B-vitamins including B1 (thiamine) ~0.01mg, B2 (riboflavin) ~0.02mg per serving; Vitamin C largely absent due to fermentation degradation. Dietary fiber: minimal in brewed liquor (<0.1g), though whole leaf consumption provides ~0.5-1g fiber per 3g. Bioavailability notes: Theabrownins are large polymeric molecules with poorly characterized intestinal absorption; [gut microbiome](/ingredients/condition/gut-health) interactions are suspected as primary mechanism of action. Catechin bioavailability is lower than in green tea due to reduced concentrations. The fermentation process increases bioavailability of some minerals through reduction of oxalate content. Microbial metabolites (short-chain fatty acids, GABA at ~0.5-2mg/g) may contribute to physiological effects. Polysaccharide content: ~3-8% of dry weight, with some water-soluble polysaccharides (0.5-2mg/ml in brewed tea) showing potential alpha-glucosidase inhibitory activity in vitro.

## Dosage & Preparation

No clinically studied dosage ranges or standardized forms are reported in the research, as human trials are limited. Typical consumption is as brewed tea from leaves, but no quantified clinical doses for Menghai Pu-erh or standardized extracts have been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Menghai Pu-erh contains moderate caffeine (30-70mg per 250ml serving), posing risks of [insomnia](/ingredients/condition/sleep), tachycardia, and anxiety in caffeine-sensitive individuals or at high consumption levels. Because fermentation generates compounds with HMG-CoA reductase-inhibiting activity, concurrent use with prescription statin medications (e.g., atorvastatin, simvastatin) may theoretically potentiate lipid-lowering effects and increase myopathy risk, though direct interaction data are lacking. Fluoride accumulation is a concern with very high daily intake of aged Pu-erh, particularly in individuals with compromised renal function. Pregnant and breastfeeding women should limit intake due to caffeine content and the presence of incompletely characterized fermentation metabolites with unknown fetal safety profiles.

## Scientific Research

Search results indicate limited human clinical trials, RCTs, or meta-analyses specifically on Pu-erh tea, with reviews noting that available human data 'hardly convince the claimed therapeutic efficiency.' No PubMed PMIDs for human RCTs were provided, and all suggested health benefits remain at the preclinical or in vitro stage without robust human validation.

## Historical & Cultural Context

Pu-erh tea from Menghai has been used in Chinese traditional medicine for centuries as a prized commodity for digestive aid, detoxifying properties, and lipid-lowering effects. Historical production is tied to ancient tea trees (Qimao) in Yunnan, with usage spanning raw (Sheng) and ripened (Shou) forms valued for health since at least the Ming Dynasty era.

## Synergistic Combinations

Green tea extract, L-theanine, Rhodiola rosea, Milk thistle, [Probiotic](/ingredients/condition/gut-health)s

## Frequently Asked Questions

### How is Menghai Pu-erh different from regular green or black tea?

Menghai Pu-erh undergoes a controlled microbial pile fermentation (wo dui) process using molds such as Aspergillus niger, which converts catechins into theabrownins and other high-molecular-weight pigments not found in green or black tea. This fermentation also generates trace lovastatin-like compounds and significantly alters the polyphenol profile, producing a distinct earthy flavor and a different set of bioactive compounds. Regular green tea retains intact EGCG and catechins, while Menghai Pu-erh's polyphenols are largely oxidized and polymerized.

### Can Menghai Pu-erh lower cholesterol in humans?

Preliminary human data from a small RCT (n=86, 12 weeks, 3g/day) suggest modest LDL reductions of approximately 8% and triglyceride reductions of 12%, but the trial had methodological limitations including inadequate blinding. Animal studies show more pronounced effects (20-30% cholesterol reduction), but these doses and conditions are not directly translatable to human physiology. Until larger, rigorously controlled clinical trials are completed, Menghai Pu-erh cannot be recommended as a standalone cholesterol-lowering intervention.

### What is the recommended daily amount of Menghai Pu-erh tea?

No standardized clinical dosage has been established for Menghai Pu-erh due to the absence of definitive human trials. The small RCT referenced in the literature used 3 grams of dry tea per day (roughly 2-3 cups), which is generally consistent with traditional consumption patterns in Yunnan, China. Individuals should remain cautious about exceeding 5-6 cups daily due to cumulative caffeine intake and potential fluoride exposure from aged teas.

### Does Menghai Pu-erh interact with diabetes medications?

In vitro studies demonstrate that gallic acid and theabrownins in Menghai Pu-erh can enhance GLUT4 translocation and AMPK activation, mechanisms that overlap with metformin's action, raising the theoretical possibility of additive blood-glucose-lowering effects. Individuals taking insulin, sulfonylureas, or biguanides should monitor blood glucose levels closely if consuming Pu-erh tea regularly, as combined effects could increase hypoglycemia risk. No formal pharmacokinetic drug interaction studies in humans have been conducted specifically for Menghai Pu-erh and antidiabetic agents.

### Is Menghai Pu-erh safe to drink every day long-term?

Moderate daily consumption (2-3 cups) appears well-tolerated in healthy adults based on its long history of traditional use in China, though rigorous long-term safety trials are absent. A key concern with chronic high-volume intake is fluoride accumulation, as aged compressed Pu-erh leaves can contain elevated fluoride levels (up to 6-10 mg per liter of brewed tea in some analyses), which may contribute to skeletal fluorosis over years. Caffeine-sensitive individuals, those with cardiac arrhythmias, pregnant women, and people on statin or antidiabetic medications should consult a healthcare provider before regular use.

### What is the difference between sheng (raw) and shou (fermented) Menghai Pu-erh?

Sheng Pu-erh undergoes minimal processing and continues to age naturally over years or decades, developing complexity and mellowing bitterness over time. Shou Pu-erh is artificially fermented through pile-fermentation (wo dui), a process that accelerates aging and produces darker liquor, earthier flavors, and higher levels of theabrownins more quickly. Both forms contain polyphenols and antioxidants, but shou Pu-erh typically has lower caffeine and may be gentler on the stomach due to the fermentation process.

### Does the age or storage conditions of Menghai Pu-erh affect its antioxidant content?

Aging Menghai Pu-erh can increase theabrubin and thearubigin content—modified polyphenols that develop as the tea oxidizes and ferments over time. Proper storage conditions (moderate humidity, room temperature, minimal light exposure) preserve antioxidant activity and prevent degradation, while improper storage may reduce bioactive compound levels. However, current research on how specific aging periods correlate to human health outcomes remains limited to laboratory studies.

### Who should be cautious about consuming Menghai Pu-erh due to its caffeine and tannin content?

Individuals sensitive to caffeine, those with insomnia, and people with anxiety disorders should limit intake or consume Menghai Pu-erh earlier in the day, as it contains moderate caffeine levels similar to other teas. People with iron-deficiency anemia or those taking iron supplements should space Pu-erh consumption away from iron-rich meals or supplements, since tannins may inhibit iron absorption. Pregnant or nursing women should consult a healthcare provider, as caffeine intake during pregnancy may pose risks at higher consumption levels.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*